Hospital admission for symptoms exacerbation in 2,075 infants suffering from recurrent asthma-like symptoms: (EISL-3 South America).

Saved in:
Bibliographic Details
Title: Hospital admission for symptoms exacerbation in 2,075 infants suffering from recurrent asthma-like symptoms: (EISL-3 South America).
Authors: Mallol J; Department of Pediatric Respiratory Medicine, Hospital El Pino, University of Santiago de Chile (USACH), Santiago, Chile; javier.mallol@usach.cl., Solé D; Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo (UNIFESP), São Paulo, Brazil., Aranda C; Division of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo (UNIFESP), São Paulo, Brazil., Toledo EC; Departamento de Pediatria e Cirurgia Pediátrica, Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brazil., Aguirre V; Department of Pediatric Respiratory Medicine, Hospital El Pino, University of Santiago de Chile (USACH), Santiago, Chile., Urrutia-Pereira M; Federal University of Pampa, Uruguayana, Rio Grande do Sul, Brazil.; Pediatric Asthma Prevention Program (PIPA), Uruguaiana, Brazil., Szulman GA; Hospital de Niños 'Ricardo Gutiérrez', Buenos Aires, Argentina., Rosario N; Department of Pediatrics, Hospital de Clínicas, Federal University of Paraná (UFPR), Curitiba, Brazil., Chong H; Department of Pediatrics, Hospital de Clínicas, Federal University of Paraná (UFPR), Curitiba, Brazil., Sanchez-Lacerda L; Department of Pediatrics, Federal University of Mato Grosso, Cuiaba, Brazil., Niederbacher J; Escuela de Medicina, Universidad Industrial de Santander, Bucaramanga, Colombia., Pinchak C; Clínica Pediátrica 'B'. Hospital Pereira Rossell, Facultad Medicina, Universidad de la Republica, Montevideo, Uruguay., de Olivera PP; Department of Pediatrics, Universidade Federal de São Carlos (UFSCAR), São Carlos, Brazil., Arruda-Chávez E; Section of Allergy and Clinical Immunology, British American Hospital, Lima, Peru., García-Marcos L; Pediatric Respiratory and Allergy Units, 'Virgen de la Arrixaca' University Children's Hospital, University of Murcia, Murcia, Spain.; IMIB Research Institute, Murcia, Spain.
Corporate Authors: EISL Phase 3 Study Group South Americao; Department of Pediatric Respiratory Medicine, Hospital El Pino, University of Santiago de Chile (USACH), Santiago, ChileDivision of Allergy, Clinical Immunology and Rheumatology, Department of Pediatrics, Federal University of São Paulo (UNIFESP), São Paulo, BrazilDepartamento de Pediatria e Cirurgia Pediátrica, Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, BrazilFederal University of Pampa, Uruguayana, Rio Grande do Sul, BrazilPediatric Asthma Prevention Program (PIPA), Uruguaiana, BrazilHospital de Niños 'Ricardo Gutiérrez', Buenos Aires, ArgentinaDepartment of Pediatrics, Hospital de Clínicas, Federal University of Paraná (UFPR), Curitiba, BrazilDepartment of Pediatrics, Federal University of Mato Grosso, Cuiaba, BrazilEscuela de Medicina, Universidad Industrial de Santander, Bucaramanga, ColombiaClínica Pediátrica 'B'. Hospital Pereira Rossell, Facultad Medicina, Universidad de la Republica, Montevideo, UruguayDepartment of Pediatrics, Universidade Federal de São Carlos (UFSCAR), São Carlos, BrazilSection of Allergy and Clinical Immunology, British American Hospital, Lima, PeruPediatric Respiratory and Allergy Units, 'Virgen de la Arrixaca' University Children's Hospital, University of Murcia, Murcia, SpainIMIB Research Institute, Murcia, SpainEISL Phase 3 Study Group South America (listed at the end of the manuscript).
Source: Allergologia et immunopathologia [Allergol Immunopathol (Madr)] 2021 Jul 01; Vol. 49 (4), pp. 47-54. Date of Electronic Publication: 2021 Jul 01 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Codon Publications Country of Publication: Singapore NLM ID: 0370073 Publication Model: eCollection Cited Medium: Internet ISSN: 1578-1267 (Electronic) Linking ISSN: 03010546 NLM ISO Abbreviation: Allergol Immunopathol (Madr) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1578-1267
DOI:10.15586/aei.v49i4.100